NerPharMa and ICROM partner on highly potent drugs and ADC-payloads

This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies

picture of

Breaking News

Lonza to supply prequalified cells for CN Bio OOC technology

Organ-on-a-chip technology has the potential to solve the issues presented by 2D cell cultures and animal models, the ...

WHP completes enzyme manufacturing facility for Biocatalysts

The UK-based company has worked with Biocatalysts Ltd through a stage-gated design process on a fully aseptic ...

Enesi Pharma hits milestone in thermostable solid-dose live vaccines development

Enesi has achieved a key milestone in development of thermostable solid-dose live vaccines against measles and rubella

Bispecific antibodies: an exciting new class of emerging therapeutics

Since 2015, when the first bispecific received US FDA approval, these game-changing antibodies have rocketed in ...

NerPharMa and ICROM partner on highly potent drugs and ADC-payloads

This agreement outlines the sharing of technologies, know-how, facilities and workforce of the two companies

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...

DMC and Conagen partner to manufacture L-alanine

L-alanine is a naturally occurring amino acid used in homecare products, human nutrition, and pharmaceutical ...

CordenPharma expands lipid excipients purification

The company has been continuously investing in expanded lipid supply chain at its facilities in Switzerland, France, ...

Accelerating excipient development for inhalable dosage forms with QbD

Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...

API sourcing: what to look for in a supplier

Jonathan Knight, Director of Market Intelligence and New Technologies at Cambrex, presents an overview of the API ...

Bispecific antibodies in review: from cell line development to manufacturing

With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific ...

Delegate tickets now on sale for Manufacturing Chemist Live

Taking place on 14-15 September, the event will provide a comprehensive overview on key pharmaceutical practices and ...

Recipharm and binx announce long-term supply agreement

Recipharm is a minority investor in binx health